Author: S. V. Pearson
Publisher: Cambridge University Press
ISBN: 0521232988
Category : Medical
Languages : en
Pages : 95
Book Description
Published when tuberculosis remained a massive problem, this 1913 volume constitutes an argument for the state provision of sanatoriums.
The State Provision of Sanatoriums
Author: S. V. Pearson
Publisher: Cambridge University Press
ISBN: 0521232988
Category : Medical
Languages : en
Pages : 95
Book Description
Published when tuberculosis remained a massive problem, this 1913 volume constitutes an argument for the state provision of sanatoriums.
Publisher: Cambridge University Press
ISBN: 0521232988
Category : Medical
Languages : en
Pages : 95
Book Description
Published when tuberculosis remained a massive problem, this 1913 volume constitutes an argument for the state provision of sanatoriums.
Interventions for Tuberculosis Control and Elimination
Author: Hans L. Rieder
Publisher:
ISBN:
Category : Tuberculosis
Languages : en
Pages : 272
Book Description
Publisher:
ISBN:
Category : Tuberculosis
Languages : en
Pages : 272
Book Description
The Medical Officer
Author:
Publisher:
ISBN:
Category : Public health administration
Languages : en
Pages : 416
Book Description
Publisher:
ISBN:
Category : Public health administration
Languages : en
Pages : 416
Book Description
Tuberculosis Control
Author: Saurabh Shrivastava
Publisher: SM Online Publishers LLC
ISBN:
Category : Medical
Languages : en
Pages : 63
Book Description
Recent global estimates suggest tuberculosis to be the second leading cause of death attributed to any infectious disease. India has the largest share of tuberculosis cases across the world and it presents as one of the biggest challenges to the public health system. To counter this menace, Government of India has initiated Revised National Tuberculosis Control Program. This book has been written to cover the different aspects of the national program, especially Directly Observed Treatment and Short Course Strategy, Drug-resistant tuberculosis, airborne infection control in hospital settings, and recent developments in the diagnostic & therapeutic aspects of tuberculosis in India. In addition, a section has been added to provide practical insights about the infamous outbreak of total-drug resistant TB in Mumbai.
Publisher: SM Online Publishers LLC
ISBN:
Category : Medical
Languages : en
Pages : 63
Book Description
Recent global estimates suggest tuberculosis to be the second leading cause of death attributed to any infectious disease. India has the largest share of tuberculosis cases across the world and it presents as one of the biggest challenges to the public health system. To counter this menace, Government of India has initiated Revised National Tuberculosis Control Program. This book has been written to cover the different aspects of the national program, especially Directly Observed Treatment and Short Course Strategy, Drug-resistant tuberculosis, airborne infection control in hospital settings, and recent developments in the diagnostic & therapeutic aspects of tuberculosis in India. In addition, a section has been added to provide practical insights about the infamous outbreak of total-drug resistant TB in Mumbai.
The British Journal of Tuberculosis
Author:
Publisher:
ISBN:
Category : Tuberculosis
Languages : en
Pages : 206
Book Description
Publisher:
ISBN:
Category : Tuberculosis
Languages : en
Pages : 206
Book Description
Development of New Antituberculosis Drugs
Author: W. W. Yew
Publisher: Nova Publishers
ISBN: 9781594548574
Category : Medical
Languages : en
Pages : 328
Book Description
In the global war to control tuberculosis (TB), there are several critical battles which must be waged and won if we are to make significant progress. Broadly speaking, these battlefields may be regarded as diagnosis, treatment and prevention. Within the arena of treatment are various critical elements. Current drug regimens require 6 months to achieve predictable cures; it is essential that shorter regimens be developed to lessen non-adherence and to improve affordability. To facilitate directly-observed therapy, intermittent (less than daily) regimens have been employed. To ensure favourable outcomes, including patients with AIDS, thrice-weekly regimens are the current standard; reducing the frequency of dosing to twice- or once-weekly may offer significant advantages. Drug resistance to the current major medications, the rifamycins and isoniazid, threatens to make tuberculosis untreatable for rising numbers of patients in many regions of the world. Finding new, effective agents is essential to ensure cures for these cases and to halt transmission of multidrug-resistant tuberculosis to others. Additional issues include reducing the side effects and toxicity of anti-tuberculosis regimens and developing regimens that can be given simultaneously with anti-retroviral therapy without deleterious drug-drug interactions or unacceptable toxicity. Finally, attention must be directed to the potential utility of treating latent infection to prevent the evolution of active disease. The current vaccine Bacille Calmette-Guerin (BCG), while protecting infants and children against potentially lethal forms of TB, has done little to control the incidence of communicable adult pulmonary disease. Research is underway to develop improved vaccines, but due to the prolonged period to determine the efficacy of a TB vaccine (a minimum of 10 to 20 years) -- alternative strategies must be pursued. Furthermore, the utility of a traditional vaccine would be sorely limited by the fact that roughly two billion persons today harbour latent tuberculosis infection. This huge reservoir of future disease would not be eligible for a traditional pre-infection vaccine. "Preventive therapy" with isoniazid has been shown to reduce the subsequent risk of tuberculosis by about 70% in large, randomised placebo-controlled clinical trials. However, this strategy is limited by the requirement for extended duration of treatment (6 to 9 months), the risks of drug-induced hepatitis and rising rates of resistance to isoniazid in many regions of the world where the TB epidemic is most intense. Alternative means for the treatment of latent tuberculosis infection should be given high priority. The authors have assembled an outstanding panel of contributors to address these issues. The topics herein have great relevance both in the industrialised nations where contemporary medications and strategies appear to have exacted their maximum benefits and for the developing nations where this ancient scourge remains rampant. This book will provide an impetus for authorities and organisations devoted to the development of new drugs to address the aforementioned growing problems of TB world-wide.
Publisher: Nova Publishers
ISBN: 9781594548574
Category : Medical
Languages : en
Pages : 328
Book Description
In the global war to control tuberculosis (TB), there are several critical battles which must be waged and won if we are to make significant progress. Broadly speaking, these battlefields may be regarded as diagnosis, treatment and prevention. Within the arena of treatment are various critical elements. Current drug regimens require 6 months to achieve predictable cures; it is essential that shorter regimens be developed to lessen non-adherence and to improve affordability. To facilitate directly-observed therapy, intermittent (less than daily) regimens have been employed. To ensure favourable outcomes, including patients with AIDS, thrice-weekly regimens are the current standard; reducing the frequency of dosing to twice- or once-weekly may offer significant advantages. Drug resistance to the current major medications, the rifamycins and isoniazid, threatens to make tuberculosis untreatable for rising numbers of patients in many regions of the world. Finding new, effective agents is essential to ensure cures for these cases and to halt transmission of multidrug-resistant tuberculosis to others. Additional issues include reducing the side effects and toxicity of anti-tuberculosis regimens and developing regimens that can be given simultaneously with anti-retroviral therapy without deleterious drug-drug interactions or unacceptable toxicity. Finally, attention must be directed to the potential utility of treating latent infection to prevent the evolution of active disease. The current vaccine Bacille Calmette-Guerin (BCG), while protecting infants and children against potentially lethal forms of TB, has done little to control the incidence of communicable adult pulmonary disease. Research is underway to develop improved vaccines, but due to the prolonged period to determine the efficacy of a TB vaccine (a minimum of 10 to 20 years) -- alternative strategies must be pursued. Furthermore, the utility of a traditional vaccine would be sorely limited by the fact that roughly two billion persons today harbour latent tuberculosis infection. This huge reservoir of future disease would not be eligible for a traditional pre-infection vaccine. "Preventive therapy" with isoniazid has been shown to reduce the subsequent risk of tuberculosis by about 70% in large, randomised placebo-controlled clinical trials. However, this strategy is limited by the requirement for extended duration of treatment (6 to 9 months), the risks of drug-induced hepatitis and rising rates of resistance to isoniazid in many regions of the world where the TB epidemic is most intense. Alternative means for the treatment of latent tuberculosis infection should be given high priority. The authors have assembled an outstanding panel of contributors to address these issues. The topics herein have great relevance both in the industrialised nations where contemporary medications and strategies appear to have exacted their maximum benefits and for the developing nations where this ancient scourge remains rampant. This book will provide an impetus for authorities and organisations devoted to the development of new drugs to address the aforementioned growing problems of TB world-wide.
British Medical Journal
Author:
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1542
Book Description
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1542
Book Description
Annual Report
Author: Great Britain. Local Government Board
Publisher:
ISBN:
Category : Local government
Languages : en
Pages : 914
Book Description
Supplements to the Board's Annual report include the: Report of the medical officer
Publisher:
ISBN:
Category : Local government
Languages : en
Pages : 914
Book Description
Supplements to the Board's Annual report include the: Report of the medical officer
Toman's Tuberculosis
Author: K. Toman
Publisher: World Health Organization
ISBN: 9241546034
Category : Medical
Languages : en
Pages : 350
Book Description
This is the second edition of a reference work aimed at all those concerned with dealing with tuberculosis control in developing countries. The book follows in the tradition of Kurt Toman's original work in this field, with the text set out in a question and answer format, grouped under three headings: case detection; treatment, and monitoring. The threat of tuberculosis is still potent, with two million deaths globally. This new edition, containing contributions from a number of experts in this field, addresses the resurgence of tuberculosis, and the emergence of multidrug-resistant bacilli, and the growth of HIV-infected individuals with tuberculosis, as well as recent scientific developments.
Publisher: World Health Organization
ISBN: 9241546034
Category : Medical
Languages : en
Pages : 350
Book Description
This is the second edition of a reference work aimed at all those concerned with dealing with tuberculosis control in developing countries. The book follows in the tradition of Kurt Toman's original work in this field, with the text set out in a question and answer format, grouped under three headings: case detection; treatment, and monitoring. The threat of tuberculosis is still potent, with two million deaths globally. This new edition, containing contributions from a number of experts in this field, addresses the resurgence of tuberculosis, and the emergence of multidrug-resistant bacilli, and the growth of HIV-infected individuals with tuberculosis, as well as recent scientific developments.
Annual Report of the Local Government Board
Author: Great Britain. Local Government Board
Publisher:
ISBN:
Category : Health status indicators
Languages : en
Pages : 904
Book Description
Publisher:
ISBN:
Category : Health status indicators
Languages : en
Pages : 904
Book Description